Temporal trends in thyroid-stimulating hormone (TSH) and thyroid peroxidase antibody (ATPO) testing across two phases of iodine fortification in Tasmania (1995-2013)

Clinical Endocrinology

Volumn 87, Issue 4, 2017, Pages 386-393

  Hong, A ^a,b   Stokes, B ^c   Otahal, P ^c   Owens, D ^b,d   Burgess, J R ^a,b  

^a ROYAL HOBART HOSPITAL   (Australia)

^b UNIVERSITY OF TASMANIA   (Australia)

^c UNIVERSITY OF TASMANIA   (Australia)

^d Diagnostic Services Pty Ltd   (Australia)

Author keywords

hyperthyroidism; hypothyroidism; iodine deficiency; thyroid function tests

Indexed keywords

IODINE; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; AUTOANTIBODY; AUTOANTIGEN; IODIDE PEROXIDASE; IRON BINDING PROTEIN; TPO PROTEIN, HUMAN;

ADULT; ARTICLE; AUTOIMMUNITY; DIET SUPPLEMENTATION; FEMALE; FOLLOW UP; FORTIFIED FOOD; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; IMMUNOASSAY; INCIDENCE; IODINE DEFICIENCY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MEDICAL RECORD; MIDDLE AGED; POPULATION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PUBLIC HOSPITAL; RETROSPECTIVE STUDY; TASMANIA; WORLD HEALTH ORGANIZATION; BLOOD; IMMUNOLOGY; METABOLISM;

ADULT; AUTOANTIBODIES; AUTOANTIGENS; FEMALE; HUMANS; IODIDE PEROXIDASE; IODINE; IRON-BINDING PROTEINS; LONGITUDINAL STUDIES; MALE; RETROSPECTIVE STUDIES; TASMANIA; THYROTROPIN;

EID: 85020550435     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.13371     Document Type: Article

References (35)

1. Garmendia Madariaga A, Santos Palacios S, Guillen-Grima F, et al. The incidence and prevalence of thyroid dysfunction in Europe: a meta-analysis. J Clin Endocrinol Metab. 2014;99:923-931.
2. Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87:489-499.
3. Valdes S, Maldonado-Araque C, Lago-Sampedro A, et al. Population-based national prevalence of thyroid dysfunction in Spain and associated factors: Di@bet.es study. Thyroid. 2017;27:156-166.
4. Walsh JP. Managing thyroid disease in general practice. Med J Aust. 2016;205:179-184.
5. Gopinath B, Wang JJ, Kifley A, et al. Five-year incidence and progression of thyroid dysfunction in an older population. Intern Med J. 2010;40:642-649.
6. Rugge JB, Bougatsos C, Chou R. Screening and treatment of thyroid dysfunction: an evidence review for the U.S. Preventive Services Task Force. Ann Intern Med. 2015;162:35-45.
7. Surks MI, Ortiz E, Daniels GH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA. 2004;291:228-238.
8. Vaidya B, Ukoumunne OC, Shuttleworth J, et al. Variability in thyroid function test requests across general practices in south-west England. Qual Prim Care. 2013;21:143-148.
9. Morgan DJ, Dhruva SS, Wright SM, et al. 2016 Update on medical overuse: a systematic review. JAMA Intern Med. 2016;176:1687-1692.
10. Moynihan R, Doust J, Henry D. Preventing overdiagnosis: how to stop harming the healthy. BMJ. 2012;344:e3502.
11. Zimmermann MB, Boelaert K. Iodine deficiency and thyroid disorders. Lancet Diabetes Endocrinol. 2015;3:286-295.
12. Eastman CJ, Zimmermann M. Thyroid physiology and disease. In: De Groot LJ, Chrousos G, Dungan K, et al., eds. The Iodine Deficiency Disorders. South Dartmouth, MA: Endotext; 2000: electronic text.
13. Carle A, Krejbjerg A, Laurberg P. Epidemiology of nodular goitre. Influence of iodine intake. Best Pract Res Clin Endocrinol Metab. 2014;28:465-479.
14. Knudsen N, Bulow I, Jorgensen T, et al. Comparative study of thyroid function and types of thyroid dysfunction in two areas in Denmark with slightly different iodine status. Eur J Endocrinol. 2000;143:485-491.
15. Bulow Pedersen I, Knudsen N, Jorgensen T, et al. Large differences in incidences of overt hyper- and hypothyroidism associated with a small difference in iodine intake: a prospective comparative register-based population survey. J Clin Endocrinol Metab. 2002;87:4462-4469.
16. van de Ven AC, Netea-Maier RT, Ross HA, et al. Longitudinal trends in thyroid function in relation to iodine intake: ongoing changes of thyroid function despite adequate current iodine status. Eur J Endocrinol. 2014;170:49-54.
17. Pedersen IB, Knudsen N, Carle A, et al. A cautious iodization programme bringing iodine intake to a low recommended level is associated with an increase in the prevalence of thyroid autoantibodies in the population. Clin Endocrinol (Oxf). 2011;75:120-126.
18. Shan Z, Chen L, Lian X, et al. Iodine status and prevalence of thyroid disorders after introduction of mandatory universal salt iodization for 16 years in China: a cross-sectional study in 10 cities. Thyroid. 2016;26:1125-1130.
19. Aghini Lombardi F, Fiore E, Tonacchera M, et al. The effect of voluntary iodine prophylaxis in a small rural community: the Pescopagano survey 15 years later. J Clin Endocrinol Metab. 2013;98:1031-1039.
20. Guttikonda K, Burgess JR, Hynes K, et al. Recurrent iodine deficiency in Tasmania, Australia: a salutary lesson in sustainable iodine prophylaxis and its monitoring. J Clin Endocrinol Metab. 2002;87:2809-2815.
21. Connolly RJ. An increase in thyrotoxicosis in southern Tasmania after an increase in dietary iodine. Med J Aust. 1971;1:1268-1271.
22. Stewart JC, Vidor GI. Thyrotoxicosis induced by iodine contamination of food-a common unrecognised condition? Br Med J. 1976;1:372-375.
23. Bulow Pedersen I, Laurberg P, Knudsen N, et al. Increase in incidence of hyperthyroidism predominantly occurs in young people after iodine fortification of salt in Denmark. J Clin Endocrinol Metab. 2006;91:3830-3834.
24. Pink BN, Pink B, Australian Bureau of Statistics. Year Book Australia 2012, 2012 edn. Canberra, ACT: Australian Bureau of Statistics; 2012, electronic text.
25. Seal JA, Doyle Z, Burgess JR, et al. Iodine status of Tasmanians following voluntary fortification of bread with iodine. Med J Aust. 2007;186:69-71.
26. Australian Bureau of Statistics. 2013. http://www.abs.gov.au/ausstats/abs@.nsf/Lookup/4364.0.55.006Chapter1202011-12. Accessed October 20, 2016.
27. Hynes KL, Otahal P, Hay I, et al. Mild iodine deficiency during pregnancy is associated with reduced educational outcomes in the offspring: 9-year follow-up of the gestational iodine cohort. J Clin Endocrinol Metab. 2013;98:1954-1962.
28. Bjergved L, Carle A, Jorgensen T, et al. Parity and 11-year serum thyrotropin and thyroid autoantibody change: a longitudinal population-based study. Thyroid. 2016;26:203-211.
29. Dunn JT. Seven deadly sins in confronting endemic iodine deficiency, and how to avoid them. J Clin Endocrinol Metab. 1996;81:1332-1335.
30. Delange F, Burgi H, Chen ZP, et al. World status of monitoring iodine deficiency disorders control programs. Thyroid. 2002;12:915-924.
31. Hynes KL, Blizzard CL, Venn AJ, et al. Persistent iodine deficiency in a cohort of Tasmanian school children: associations with socio-economic status, geographical location and dietary factors. Aust N Z J Public Health. 2004;28:476-481.
32. Laurberg P, Jorgensen T, Perrild H, et al. The Danish investigation on iodine intake and thyroid disease, DanThyr: status and perspectives. Eur J Endocrinol. 2006;155:219-228.
33. Vejbjerg P, Knudsen N, Perrild H, et al. Lower prevalence of mild hyperthyroidism related to a higher iodine intake in the population: prospective study of a mandatory iodization programme. Clin Endocrinol (Oxf). 2009;71:440-445.
34. Bayram C, Valenti L, Britt H. Orders for thyroid function tests-changes over 10 years. Aust Fam Physician. 2012;41:555.
35. Vaccarella S, Franceschi S, Bray F, et al. Worldwide thyroid-cancer epidemic? The increasing impact of overdiagnosis. N Engl J Med. 2016;375:614-617.